ID: ALA5272786

Max Phase: Preclinical

Molecular Formula: C19H10N2O4

Molecular Weight: 330.30

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1cc2c(o1)-c1nccc3c1c(nc1ccccc13)C2=O

Standard InChI:  InChI=1S/C19H10N2O4/c1-24-19(23)13-8-11-17(22)15-14-10(6-7-20-16(14)18(11)25-13)9-4-2-3-5-12(9)21-15/h2-8H,1H3

Standard InChI Key:  GLQGTGZBHNQVDM-UHFFFAOYSA-N

Associated Targets(non-human)

Mycobacterium 258 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 330.30Molecular Weight (Monoisotopic): 330.0641AlogP: 3.37#Rotatable Bonds: 1
Polar Surface Area: 82.29Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.71CX LogP: 2.79CX LogD: 2.79
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.35Np Likeness Score: 0.48

References

1. Mishra SK, Tripathi G, Kishore N, Singh RK, Singh A, Tiwari VK..  (2017)  Drug development against tuberculosis: Impact of alkaloids.,  137  [PMID:28628823] [10.1016/j.ejmech.2017.06.005]

Source